ARCHIVES

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

CMS will pay oncologists to report adherence to practice guidelines.

November 4, 2005

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

Four More Cooperative Groups Disapproved As NCI to Consider New Directions in Clinical Trials

March 28, 1986

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988